Eris Lifesciences declared the acquisition of Biocon Biologics' India-marked detailing business for Rs. 1,242 crore. Eris has likewise marked a 10-year supply concurrence with Biocon Biologics on account of this agreement...
Xcode Life, a prominent personal genomics company in India, has recently launched a new genetic test named "Genes and Caffeine."
The American Oncology Institute (AOI) at Babina Specialty Hospital in Imphal has recently initiated iodine therapy to treat thyroid cancer.
NephroPlus, the leading multinational dialysis care provider and Asia's largest dialysis network, recently announced the successful acquisition of Renal Therapy Solutions Inc. (RTSI).
According to a recent report by the World Health Organization, the gender gap in global healthcare is still a pressing issue.
Pfizer Inc. has announced that the European Commission (EC) has granted marketing authorization for Prevenar 20, the company's 20-valent pneumococcal conjugate vaccine, for active immunization in infants, children, and adolescents
Sanofi India Limited (SIL) recently obtained approval from its board of directors for an exclusive distribution and promotion agreement with Emcure Pharmaceuticals Limited (Emcure).
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorization to Daiichi Sankyo UK Ltd.
NephroPlus, a multinational leader in dialysis care and Asia's largest dialysis network announces the recent acquisition of Renal Therapy Solutions Inc. (RTSI), a well-known dialysis network with six clinics in the Philippines.
Pfizer Inc. recently announced positive results from a phase 3 clinical study of the antibody-drug conjugate Adcetris (brentuximab vedotin), used in combination with lenalidomide and rituximab for treating patients
, CDSCO.jpg)
